Newron Pharmaceuticals S.P.A based in Bresso, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-06-16 ✅ Patent 12,291,495 granted on 2025-05-06

US20220185766A1

Chemistry; metallurgy

Process for the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivatives

#2 | 2022-06-09 ✅ Patent 12,134,589 granted on 2024-11-05

US20220177417A1

Chemistry; metallurgy

Process for the production of substituted 2-[2-(phenyl) ethylaminojalkaneamide derivatives

#3 | 2015-06-11 ✅ Patent 9,603,832 granted on 2017-03-28

US20150157602A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#4 | 2015-06-11 ✅ Patent 9,474,739 granted on 2016-10-25

US20150157601A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#5 | 2015-06-11 ✅ Patent 9,474,738 granted on 2016-10-25

US20150157600A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#6 | 2015-06-11 ✅ Patent 9,474,737 granted on 2016-10-25

US20150157599A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#7 | 2015-06-11 ✅ Patent 9,585,869 granted on 2017-03-07

US20150157598A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#8 | 2015-06-04 ✅ Patent 9,492,410 granted on 2016-11-15

US20150150833A1

Human necessities

Methods for treatment of Parkinson's disease

#9 | 2014-02-20 ✅ Patent 8,846,763 granted on 2014-09-30

US20140051758A1

Chemistry; metallurgy

High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof

#10 | 2013-10-31 ✅ Patent 9,248,116 granted on 2016-02-02

US20130289122A1

Chemistry; metallurgy

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#11 | 2013-10-17 ✅ Patent 9,051,240 granted on 2015-06-09

US20130274249A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#12 | 2013-08-22 ✅ Patent 8,697,738 granted on 2014-04-15

US20130217747A1

Human necessities

Alpha-aminoamide derivatives useful in the treatment of addictive disorders

#13 | 2013-02-28 ✅ Patent 8,901,176 granted on 2014-12-02

US20130053368A1

Human necessities

Methods for treatment of Parkinson's disease

#14 | 2012-06-21 ✅ Patent 8,278,485 granted on 2012-10-02

US20120157712A1

Chemistry; metallurgy

Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides

#15 | 2011-12-27 ✅ Patent 8,084,447 granted on 2011-12-27

US10487931

Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use

#16 | 2011-02-24 ✅ Patent 8,129,427 granted on 2012-03-06

US20110046129A1

Chemistry; metallurgy

2-phenylethylamino derivatives as calcium and/or sodium channel modulators

#17 | 2011-01-20 ✅ Patent 8,445,539 granted on 2013-05-21

US20110014304A1

Human necessities

Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders

#18 | 2010-12-23 ✅ Patent 8,530,701 granted on 2013-09-10

US20100324141A1

Chemistry; metallurgy

High purity 2-[4-(3- OR 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof

#19 | 2010-08-19 ✅ Patent 8,519,000 granted on 2013-08-27

US20100210631A1

Human necessities

Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators

#20 | 2010-08-05

US20100197799A1

Chemistry; metallurgy

HYDROXYLAMINE DERIVATIVES

#21 | 2010-02-25 ✅ Patent 8,063,039 granted on 2011-11-22

US20100048665A1

Chemistry; metallurgy

3-aminopyrrolidone derivatives

#22 | 2009-06-18 ✅ Patent 8,076,515 granted on 2011-12-13

US20090156678A1

Chemistry; metallurgy

Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides

#23 | 2008-06-05 ✅ Patent 7,718,815 granted on 2010-05-18

US20080132567A1

Human necessities

Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders

#24 | 2007-08-30 ✅ Patent 8,445,513 granted on 2013-05-21

US20070203182A1

Human necessities

α-Aminoamide derivatives useful in the treatment of restless legs syndrome

#25 | 2007-06-21 ✅ Patent 7,411,091 granted on 2008-08-12

US20070142455A1

Chemistry; metallurgy

N-acyl-N′-benzyl-alkylendiamino derivatives

#26 | 2007-06-14 ✅ Patent 7,649,005 granted on 2010-01-19

US20070135496A1

Chemistry; metallurgy

Substituted benzylaminoalkylene heterocycles

#27 | 2007-06-14 ✅ Patent 7,968,592 granted on 2011-06-28

US20070135410A1

Chemistry; metallurgy

3-aminopyrrolidone derivatives

#28 | 2007-04-26 ✅ Patent 8,283,380 granted on 2012-10-09

US20070093495A1

Human necessities

Methods for treatment of parkinson's disease

#29 | 2007-03-22 ✅ Patent 7,265,244 granted on 2007-09-04

US20070066688A1

Chemistry; metallurgy

Cyclopentyl derivatives

#30 | 2007-03-01 ✅ Patent 7,763,751 granted on 2010-07-27

US20070049643A1

Chemistry; metallurgy

Hydroxylamine derivatives

Also check out Newron Pharmaceuticals S.p.A.'s (Bresso, Italy) applicant profile with 11 patent applications submitted.

AssigneeID:

11763 ⎘